SEC Filing - MedAvail

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Alyeska Investment Group, L.P.

(Last)

(First)

(Middle)

77 WEST WACKER DRIVE, 7TH FLOOR

(Street)

CHICAGO

60601

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/04/2022

3. Issuer Name and Ticker or Trading Symbol
MedAvail Holdings, Inc. [ MDVL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	7,539,411	D
Common Stock⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	7,539,411	D
Common Stock⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	7,539,411	I	Footnotes⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	7,539,411	I	Footnotes⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	7,539,411	I	Footnotes⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	7,539,411	I	Footnotes⁽²⁾⁽³⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrants⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	04/04/2022	04/04/2027	Common Stock	3,764,705	1.25	D
Warrants⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	04/04/2022	04/04/2027	Common Stock	3,764,705	1.25	D
Warrants⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	04/04/2022	04/04/2027	Common Stock	3,764,705	1.25	I	Footnotes⁽²⁾⁽³⁾
Warrants⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	04/04/2022	04/04/2027	Common Stock	3,764,705	1.25	I	Footnotes⁽²⁾⁽³⁾
Warrants⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	04/04/2022	04/04/2027	Common Stock	3,764,705	1.25	I	Footnotes⁽²⁾⁽³⁾
Warrants⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	04/04/2022	04/04/2027	Common Stock	3,764,705	1.25	I	Footnotes⁽²⁾⁽³⁾

1. Name and Address of Reporting Person^*

Alyeska Investment Group, L.P.

(Last)

(First)

(Middle)

77 WEST WACKER DRIVE, 7TH FLOOR

(Street)

CHICAGO

60601

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

Alyeska Master Fund, L.P.

(Last)

(First)

(Middle)

77 WEST WACKER DRIVE, 7TH FLOOR

(Street)

CHICAGO

60601

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

ALYESKA FUND GP, LLC

(Last)

(First)

(Middle)

77 WEST WACKER DRIVE, 7TH FLOOR

(Street)

CHICAGO

60601

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

ALYESKA INVESTMENT GROUP, LLC

(Last)

(First)

(Middle)

77 WEST WACKER DRIVE, 7TH FLOOR

(Street)

CHICAGO

60601

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

ALYESKA INVESTMENTS, LLC

(Last)

(First)

(Middle)

77 WEST WACKER DRIVE, 7TH FLOOR

(Street)

CHICAGO

60601

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

PAREKH ANAND

(Last)

(First)

(Middle)

77 WEST WACKER DRIVE, 7TH FLOOR

(Street)

CHICAGO

60601

(City)

(State)

(Zip)

Explanation of Responses:

1. Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of Alyeska Master Fund, L.P. (the "Fund"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Fund. The Fund is the direct owner of 7,539,411 shares of Common Stock, par value $0.001 per share ("Shares"), of MedAvail Holdings, Inc. and warrants to purchase 3,764,705 Shares ("Warrants"). The Warrants cannot be exercised if, after giving effect thereto, the Fund would beneficially own more than 9.99% of the total outstanding Shares of MedAvail Holdings, Inc. The Investment Manager receives an asset-based fee relating to the Shares and Warrants directly held by the Fund, and does not hold a pecuniary interest in such Shares or Warrants.

2. (i) Alyeska Fund GP, LLC is the general partner of the Fund and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (ii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC, and has an indirect profits interest in the Shares and Warrants directly held by the Fund; (iii) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund; and (iv) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares and Warrants directly held by the Fund.

3. The filing of this Form 3 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares or Warrants. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.

4. The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16(a)-3(j) under the Exchange Act.

Remarks:

	Alyeska Investment Group, L.P., By: /s/ Jason Bragg, Chief Financial Officer	05/23/2022
	Alyeska Master Fund, L.P., By: Alyeska Fund GP, LLC , By: /s/ Jason Bragg, Chief Financial Officer	05/23/2022
	Alyeska Fund GP, LLC, By: /s/ Jason Bragg, Chief Financial Officer	05/23/2022
	Alyeska Investment Group, LLC, By: /s/ Jason Bragg, Chief Financial Officer	05/23/2022
	Alyeska Investments, LLC, By: /s/ Anand Parekh, Managing Member	05/23/2022
	/s/ Anand Parekh	05/23/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.